A retrospective, head to head comparison study for thromboembolic stroke, intracranial hemorrhage (ICH), major extracranial bleeding including and mortality in elderly patients treated with dabigatran and rivaroxaban for nonvalvular Atrial Fibrillation .

Trial Profile

A retrospective, head to head comparison study for thromboembolic stroke, intracranial hemorrhage (ICH), major extracranial bleeding including and mortality in elderly patients treated with dabigatran and rivaroxaban for nonvalvular Atrial Fibrillation .

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2016

At a glance

  • Drugs Rivaroxaban (Primary) ; Dabigatran etexilate
  • Indications Atrial fibrillation
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Nov 2016 Status changed to completed.
    • 15 Nov 2016 New trial record
    • 03 Oct 2016 Primary end point (Thromboembolic stroke) has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top